RFA
KURA icon

Reilly Financial Advisors’s Kura Oncology KURA Stock Holding History

Reilly Financial Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200
Closed -$1K – 945
2016
Q4 		$1K Hold
200
– – ﹤0.01% 801
2016
Q3 		$1K Buy
+200
New +$1.01K ﹤0.01% 797

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Reilly Financial Advisors's KURA Position: Q1 2017 in Review

Reilly Financial Advisors sold out of Kura Oncology (KURA) in Q1 2017, closing a stake of 200 shares — an estimated $1K sold.

Reilly Financial Advisors first reported a position in KURA in Q3 2016 and held it in 2 quarters. The position peaked at $1K in Q4 2016. 35 funds tracked by Wall St. Rank hold KURA as of Q1 2017.

  • Reilly Financial Advisors reported no remaining Kura Oncology position as of Q1 2017 after selling out during the quarter.
  • Reilly Financial Advisors sold 200 Kura Oncology shares in Q1 2017, an estimated $1K.
  • Reilly Financial Advisors first reported a position in Kura Oncology in Q3 2016 and held it in 2 quarters.
  • Reilly Financial Advisors's Kura Oncology position peaked at $1K in Q4 2016.
  • 35 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2017.

Based on Reilly Financial Advisors's 13F filing for Q1 2017, filed 18 Apr 2017.